Design and development of the molecular analysis for Therapy Choice (NCI-MATCH) Designated Laboratory Network.

James V. Tricoli,Linda Zane,Robin D. Harrington,Laura Yee,Kneshay N. Harper,Ting Chia Chang,Lyndsay Harris,Alice P. Chen,Keith T. Flaherty,Peter J. O’Dwyer,Barbara A. Conley,Cynthia Winter,Jennifer M. Lee,Paul Williams,Jeffrey Sklar,David Patton,Gregory J. Tsongalis,Stanley R. Hamilton,A. John Iafrate,Chris Karlovich

Design and development of the molecular analysis for Therapy Choice (NCI-MATCH) Designated Laboratory Network.

2019

3016Background: NCI-MATCH is a precision medicine trial that assigns treatment to refractory cancer patients by tumor mutation profile rather than by histology. After screening fresh tumor biopsies...

Keywords:

Medical physics
Physical therapy
Medicine
molecular analysis
Refractory cancer
Internal medicine
Oncology
Pathology
Precision medicine
Histology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations